CONSTELLATION PHARMACEUTICALS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-09-27. The offering totals $24.3M, of which $24.3M was reported sold. Industry: Biotechnology.
Showing 25 of 33 people.
| Name | Role | Location |
|---|---|---|
| Anthony A Evnin | Director | Cambridge, MA |
| Tom A Maniatis | Director | Cambridge, MA |
| Peter A Svennilson | Director | Cambridge, MA |
| James E Audia | Executive Officer | Cambridge, MA |
| Michael R Cooper | Executive Officer | Cambridge, MA |
| Mark A Goldsmith | Executive Officer | Redwood City, CA |
| Matthias E Jaffe | Executive Officer | Cambridge, MA |
| Peter Svennilson | Director | South San Francisco, CA |
| Jigar Raythatha | Director | Boston, MA |
| Jigar Raythatha | Executive Officer | Boston, MA |
| David Goeddel | Director | Agoura Hills, CA |
| Elizabeth G Trehu | Director | Cambridge, MA |
| Mark A Goldsmith | Director | Redwood City, CA |
| Anthony Evnin | Director | Cambridge, MA |
| Robert A Tepper | Director | Cambridge, MA |
| James E Audia | Director | Cambridge, MA |
| Patrick G Trojer | Executive Officer | Cambridge, MA |
| Steven G Hoerter | Director | Cambridge, MA |
| Scott G Braunstein | Director | Cambridge, MA |
| Adrian G Senderowicz | Executive Officer | Cambridge, MA |
| Karen G Valentine | Executive Officer | Cambridge, MA |
| Emma E Reeve | Executive Officer | Cambridge, MA |
| Keith Dionne | Director | Belmont, MA |
| Keith Dionne | Executive Officer | Belmont, MA |
| David A Goeddel | Director | Cambridge, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2019-10-08 | D | $65.0M | $65.0M |
| 2018-04-06 | D | $100.0M | $99.0M |
| 2015-12-15 | D | $55.8M | $55.8M |
| 2014-08-05 | D | $5.0M | $5.0M |
| 2011-06-06 | D | $15.0M | $15.0M |
| 2010-06-02 | D | $22.3M | $22.3M |